HARBIN, China, April 2, 2008 /Xinhua-PRNewswire-FirstCall/ -- China Sky
One Medical, Inc. (OTC Bulletin Board: CSKI) ("China Sky One" or "the
Company"), a manufacturer, marketer and distributor of pharmaceutical,
medicinal and diagnostic products in China, today announced record
financial results for the fourth quarter and fiscal year ended December 31,
2007.
Fourth Quarter 2007 Highlights
-- Total revenues increased to $12.7 million, up 223% from the fourth
quarter of 2006
-- Gross profit reached $9.9 million, up 201% from the fourth quarter of
2006
-- Operating income totaled $4.9 million, up from a loss of $532,262 in
the fourth quarter of 2006
-- Net income increased to $4.1 million, or $0.31 per diluted share, up
from a loss of $1.0 million, or ($0.08) per diluted share, in the
fourth quarter of 2006
Full Year 2007 Highlights
-- Total revenues increased 148% in 2007 to $49.3 million
-- Gross profit increased 159% in 2007 to $38.4 million
-- Gross profit margin increased 328 basis points to 77.8%
-- Operating income increased 863% to $18.6 million
-- Net income increased to $15.3 million, or $1.15 per diluted share, up
from $0.6 million, or $0.05 per diluted share in 2006
-- New Bio-Chemical Products series generated $3 million in revenue in
2007
-- Began exporting to overseas markets, generating $12.4 million in
revenues
-- Entered into an exclusive strategic partnership with Takasima
Industries to sell the Company's patch products in Malaysia
"This was a very successful year for China Sky One, both in terms of
financial performance and the execution of our business strategy. We
achieved significant growth in revenues, due in large part to our strategy
of hiring direct territory managers and sales agents to assure that our
products and their benefits are reaching our customers.
'/>"/>
| SOURCE China Sky One Medical, Inc. Copyright©2008 PR Newswire. All rights reserved |